Lymphangioleiomyomatosis
📧 Sign up to get email alerts when something new happens for Lymphangioleiomyomatosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Discovery of Sirolimus Sensitive Biomarkers in Blood [Phase 2]
Phase 2 clinical trial investigating sirolimus-sensitive biomarkers in the blood of patients with lymphangioleiomyomatosis; results have bee…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Feasibility of [11C]Acetate-PET in LAM and TSC [Phase 1, Phase 2]
Phase 1/2 feasibility study evaluating [11C]Acetate-PET imaging in lymphangioleiomyomatosis and tuberous sclerosis complex. Results have bee…
-
CLINICAL_TRIALS trial_result · 2024-04-17Clinical Trial Update: Letrozole for Lymphangioleiomyomatosis [Phase 2]
Phase 2 clinical trial update for letrozole in lymphangioleiomyomatosis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-11-02Clinical Trial Update: Efficacy and Safety of Sirolimus in LAM [Phase 3]
Phase 3 clinical trial assessing efficacy and safety of sirolimus in lymphangioleiomyomatosis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-02-01Clinical Trial Update: Resveratrol and Sirolimus in Lymphangioleiomyomatosis Trial [Phase 2]
Phase 2 clinical trial evaluating resveratrol and sirolimus in lymphangioleiomyomatosis has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-09-28Clinical Trial Update: A Study of Nintedanib for LymphAngioleioMyomatosis (LAM) [Phase 2]
Phase 2 clinical trial of nintedanib for lymphangioleiomyomatosis (LAM) has completed.
-
CLINICAL_TRIALS trial_result · 2022-01-27Clinical Trial Update: Effect of Loratadine in Lymphangioleiomyomatosis [Phase 2]
Phase 2 trial assessing loratadine for lymphangioleiomyomatosis is listed with an unknown status.
-
CLINICAL_TRIALS trial_result · 2022-01-20Clinical Trial Update: COLA: A Pilot Clinical Trial of COX-2 Inhibition in LAM and TSC [Phase 2]
Phase 2 pilot trial of COX-2 inhibition in LAM completed; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2020-11-19Clinical Trial Update: A Study to Determine the Safety and Effectiveness of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis [Phase 2]
Phase 2 clinical trial updating safety and effectiveness of everolimus (RAD001) in lymphangioleiomyomatosis (LAM).
-
CLINICAL_TRIALS trial_result · 2020-08-25Clinical Trial Update: Safety of Simvastatin in LAM and TSC [Phase 1, Phase 2]
A Phase 1/2 trial reported on the safety of simvastatin in patients with Lymphangioleiomyomatosis and Tuberous Sclerosis Complex; study comp…
-
CLINICAL_TRIALS trial_result · 2020-03-26Clinical Trial Update: LAM Pilot Study With Imatinib Mesylate [Phase 1, Phase 2]
A pilot study investigating imatinib mesylate for lymphangioleiomyomatosis has completed Phase 1 and Phase 2 with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2018-10-11Clinical Trial Update: Safety Study of Sirolimus and Hydroxychloroquine in Women With Lymphangioleiomyomatosis [Phase 1]
Phase 1 safety study evaluating sirolimus with hydroxychloroquine in women with lymphangioleiomyomatosis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: The Effect of Lt to Rt Shunt Using Veno-veno-arterial Extracorporeal Membrane Oxygenation (ECMO) on Coronary Oxygenation in Lung Transplantation Patients [NA]
A completed clinical trial evaluated whether a left-to-right shunt using veno-veno-arterial ECMO improves coronary oxygenation in lung trans…
-
CLINICAL_TRIALS trial_result · 2016-11-30Clinical Trial Update: The Tolerability of Saracatinib in Subjects With Lymphangioleiomyomatosis (LAM) (SLAM-1) [Phase 1]
This Phase 1 trial assesses the tolerability of Saracatinib in subjects with lymphangioleiomyomatosis, and the study status is completed.
-
CLINICAL_TRIALS trial_result · 2015-12-11Clinical Trial Update: Pulmonary Rehabilitation in Lymphangioleiomyomatosis [NA]
The clinical trial evaluating pulmonary rehabilitation in lymphangioleiomyomatosis has been completed.
-
CLINICAL_TRIALS trial_result · 2015-12-02Clinical Trial Update: Doxycycline In Lymphangioleiomyomatosis (LAM) [Phase 4]
Phase 4 trial of doxycycline in lymphangioleiomyomatosis (LAM) has been completed, including cases associated with tuberous sclerosis comple…
-
CLINICAL_TRIALS trial_result · 2013-09-25Clinical Trial Update: RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAM [Phase 1, Phase 2]
A Phase 1/2 trial evaluated the mTOR inhibitor everolimus (RAD001) for angiomyolipomata in patients with tuberous sclerosis complex and spor…
-
CLINICAL_TRIALS trial_result · 2013-09-18Clinical Trial Update: Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM) [Phase 1, Phase 2]
Long-term follow-up results for everolimus (RAD001) therapy in patients with tuberous sclerosis complex-associated angiomyolipoma and sporad…
-
CLINICAL_TRIALS trial_result · 2012-08-28Clinical Trial Update: Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM) [Phase 3]
Phase 3 trial assessing the efficacy and safety of everolimus (RAD001) in adults with angiomyolipoma associated with tuberous sclerosis comp…
-
CLINICAL_TRIALS trial_result · 2011-10-27Clinical Trial Update: Pulmonary Hypertension in Lymphangioleiomyomatosis
A clinical trial evaluating pulmonary hypertension in lymphangioleiomyomatosis has completed.
-
CLINICAL_TRIALS trial_result · 2010-04-30Clinical Trial Update: Treatment With Octreotide in Patients With Lymphangioleiomyomatosis [Phase 2]
A Phase 2 trial evaluating octreotide in patients with lymphangioleiomyomatosis was completed, with results posted in 2010. The sponsor was …
-
CLINICAL_TRIALS trial_result · 2008-04-30Clinical Trial Update: Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM [Phase 2]
Phase 2 trial evaluating the efficacy and safety of sirolimus in tuberous sclerosis complex and lymphangioleiomyomatosis.
-
CLINICAL_TRIALS trial_result · 2007-04-09Clinical Trial Update: Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM [Phase 2]
Phase 2 clinical trial update reports on rapamycin therapy for patients with tuberous sclerosis complex and sporadic lymphangioleiomyomatosi…